Dr Gary Charles Rosenblum, DO | |
120 Mineola Blvd, Suite 410, Mineola, NY 11501-4073 | |
(516) 663-4751 | |
(516) 663-2946 |
Full Name | Dr Gary Charles Rosenblum |
---|---|
Gender | Male |
Speciality | Rheumatology |
Experience | 37 Years |
Location | 120 Mineola Blvd, Mineola, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194706556 | NPI | - | NPPES |
01556270 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | NYS176247 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
New York University Langone Medical Center | New york, NY | Hospital |
Nassau University Medical Center | East meadow, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
New York University | 1355232422 | 4431 |
Nassau Health Care Corporation | 2961315221 | 163 |
News Archive
A bicoastal group of scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) was recently awarded a three-year grant from the U.S. Department of the Air Force to assess the potential toxicity of large collections of chemicals.
With at least two in three Australians diagnosed with skin cancer before the age of 70, monitoring moles and skin is vital in detecting skin cancer early for a generation of people who spent much of their upbringing in the sun (often with little to no protection).
The Council for Citizens Against Government Waste today called upon Congress to reject any attempts to alter the nation's healthcare system using parliamentary gimmicks and urged members to vote against the bill.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
› Verified 5 days ago
Entity Name | Nassau Health Care Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902822992 PECOS PAC ID: 2961315221 Enrollment ID: O20040619000043 |
News Archive
A bicoastal group of scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) was recently awarded a three-year grant from the U.S. Department of the Air Force to assess the potential toxicity of large collections of chemicals.
With at least two in three Australians diagnosed with skin cancer before the age of 70, monitoring moles and skin is vital in detecting skin cancer early for a generation of people who spent much of their upbringing in the sun (often with little to no protection).
The Council for Citizens Against Government Waste today called upon Congress to reject any attempts to alter the nation's healthcare system using parliamentary gimmicks and urged members to vote against the bill.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
› Verified 5 days ago
Entity Name | New York University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
A bicoastal group of scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) was recently awarded a three-year grant from the U.S. Department of the Air Force to assess the potential toxicity of large collections of chemicals.
With at least two in three Australians diagnosed with skin cancer before the age of 70, monitoring moles and skin is vital in detecting skin cancer early for a generation of people who spent much of their upbringing in the sun (often with little to no protection).
The Council for Citizens Against Government Waste today called upon Congress to reject any attempts to alter the nation's healthcare system using parliamentary gimmicks and urged members to vote against the bill.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
› Verified 5 days ago
Entity Name | Winthrop Community Medical Affiliates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457873077 PECOS PAC ID: 5698092385 Enrollment ID: O20150317001669 |
News Archive
A bicoastal group of scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) was recently awarded a three-year grant from the U.S. Department of the Air Force to assess the potential toxicity of large collections of chemicals.
With at least two in three Australians diagnosed with skin cancer before the age of 70, monitoring moles and skin is vital in detecting skin cancer early for a generation of people who spent much of their upbringing in the sun (often with little to no protection).
The Council for Citizens Against Government Waste today called upon Congress to reject any attempts to alter the nation's healthcare system using parliamentary gimmicks and urged members to vote against the bill.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Gary Charles Rosenblum, DO 120 Mineola Blvd, Suite 410, Mineola, NY 11501-4073 Ph: (516) 663-4751 | Dr Gary Charles Rosenblum, DO 120 Mineola Blvd, Suite 410, Mineola, NY 11501-4073 Ph: (516) 663-4751 |
News Archive
A bicoastal group of scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) was recently awarded a three-year grant from the U.S. Department of the Air Force to assess the potential toxicity of large collections of chemicals.
With at least two in three Australians diagnosed with skin cancer before the age of 70, monitoring moles and skin is vital in detecting skin cancer early for a generation of people who spent much of their upbringing in the sun (often with little to no protection).
The Council for Citizens Against Government Waste today called upon Congress to reject any attempts to alter the nation's healthcare system using parliamentary gimmicks and urged members to vote against the bill.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
› Verified 5 days ago
Dr. Marlene Martins Lobato, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 173 Mineola Blvd, Suite 403, Mineola, NY 11501 Phone: 516-741-8891 Fax: 516-741-8829 | |
Michael Garrison, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 200 Old Country Rd, Suite 450, Mineola, NY 11501 Phone: 516-663-9500 Fax: 516-663-4613 | |
Dr. Anupama Ananda, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 190 Willis Ave, Suite 210, Mineola, NY 11501 Phone: 516-739-7290 Fax: 516-793-7291 | |
Mr. Jeffrey Liu, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 297 Mineola Blvd, Mineola, NY 11501 Phone: 516-294-1377 Fax: 516-294-5574 | |
Dr. Jonathan Shulman, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-2381 | |
John I Hogan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 222 Station Plz N Ste 432, Mineola, NY 11501 Phone: 516-663-2507 | |
Dr. Anthony Massimillo, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 300 Old Country Rd Ste 31, Mineola, NY 11501 Phone: 516-294-9380 Fax: 516-294-5351 |